AstraZeneca logo

AstraZeneca

Stock
Stock
ISIN: GB0009895292
Ticker: AZN
GB0009895292
AZN

Price

Price

CHART BY

Historical dividends and forecast

All dividend data

AstraZeneca has so far distributed $3.219 in 2026. The next dividend will be paid on 23.03.2027


$2.917

CHART BY

Frequently asked questions

The market capitalization of AstraZeneca is $245.76B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
The Price-to-Earnings (P/E) ratio (TTM) for AstraZeneca is 23.33. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
AstraZeneca's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $5.019. EPS indicates the company's profitability on a per-share basis.
Currently, 33 analysts cover AstraZeneca's stock, with a consensus target price of $217.30. Analyst ratings provide insights into the stock's expected performance.
Over the trailing twelve months, AstraZeneca reported a revenue of $45.73B.
AstraZeneca's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $14.97B. EBITDA measures the company's overall financial performance.
AstraZeneca has a free cash flow of $8.16B. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
AstraZeneca employs approximately 96,100 people. It operates in the Health Care sector, specifically within the Major Pharmaceuticals industry.
The free float of AstraZeneca is 1.50B. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$245.76B
EPS (TTM) 
$5.019
Free Float 
1.50B
P/E ratio (TTM) 
23.33
Revenue (TTM) 
$45.73B
EBITDA (TTM) 
$14.97B
Free Cashflow (TTM) 
$8.16B

Pricing

1D span
$158.36$161.45
52W span
$144.53$212.29

Analyst Ratings

The price target is $217.30 and the stock is covered by 33 analysts.

Buy

28

Hold

4

Sell

1

Information

AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. The company was founded in 1913 and is headquartered in Cambridge, the United Kingdom.

Employees
96,100
Industries
Major Pharmaceuticals
Sector
Health Care

Identifier

ISIN
GB0009895292
Primary Ticker
AZN

Knockouts

Real-time data from LSX · Fundamentals & EOD data from FactSet
Join the conversation